MC-VC-PAB-MMAF | CAS#863971-17-9 | MMAF derivative

MedKoo Cat#: 408191 | Name: MC-VC-PAB-MMAF

Description:

WARNING: This product is for research use only, not for human or veterinary use.

MC-VC-PAB-MMAF, also known as MC-Val-Cit-PAB-MMAF and Vc-MMAF, is a MMAF (Monomethylauristatin F) derivative with a reactive linker have a maleimido functional group in the end. MC-VC-PAB-MMAF is a useful compound to make MMAF antibody drug conjugates for cancer treatment. MMAF is a potent tubulin polymerization inhibitor with antitumor activity.

Chemical Structure

MC-VC-PAB-MMAF

CAS#863971-17-9

Theoretical Analysis

MedKoo Cat#: 408191

Name: MC-VC-PAB-MMAF

CAS#: 863971-17-9

Chemical Formula: C68H103N11O16

Exact Mass: 1329.7584

Molecular Weight: 1330.63

Elemental Analysis: C, 61.38; H, 7.80; N, 11.58; O, 19.24

Price and Availability

Size	Price	Availability
5mg	USD 550.00	2 Weeks
10mg	USD 850.00	2 Weeks
25mg	USD 1,550.00	2 Weeks
50mg	USD 2,450.00	2 Weeks
100mg	USD 4,250.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

MC-VC-PAB-MMAF; MC-Val-Cit-PAB-MMA; Vc-MMAF;

IUPAC/Chemical Name

((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-((((4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl)oxy)carbonyl)(methyl)amino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoyl)-L-phenylalanine

InChi Key

BDITVJHHJUTHBB-DNIGJBFUSA-N

InChi Code

InChI=1S/C68H103N11O16/c1-14-43(8)59(51(93-12)38-55(83)78-36-22-26-50(78)60(94-13)44(9)61(84)73-49(66(89)90)37-45-23-17-15-18-24-45)76(10)65(88)57(41(4)5)75-64(87)58(42(6)7)77(11)68(92)95-39-46-28-30-47(31-29-46)71-62(85)48(25-21-34-70-67(69)91)72-63(86)56(40(2)3)74-52(80)27-19-16-20-35-79-53(81)32-33-54(79)82/h15,17-18,23-24,28-33,40-44,48-51,56-60H,14,16,19-22,25-27,34-39H2,1-13H3,(H,71,85)(H,72,86)(H,73,84)(H,74,80)(H,75,87)(H,89,90)(H3,69,70,91)/t43-,44+,48-,49-,50-,51+,56-,57-,58-,59-,60+/m0/s1

SMILES Code

OC([C@H](CC1=CC=CC=C1)NC([C@H](C)[C@H]([C@@]2([H])N(CCC2)C(C[C@@H](OC)[C@@]([C@@H](C)CC)([H])N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)C(OCC3=CC=C(NC([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC(CCCCCN4C(C=CC4=O)=O)=O)=O)=O)C=C3)=O)=O)=O)=O)OC)=O)=O

Appearance

To be determined

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 1,330.63 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Chudasama V, Maruani A, Caddick S. Recent advances in the construction of antibody-drug conjugates. Nat Chem. 2016 Feb;8(2):114-9. doi: 10.1038/nchem.2415. Epub 2016 Jan 4. Erratum in: Nat Chem. 2016 Mar;8(3):281. Erratum in: Nat Chem. 2016 Mar;8(3):281. doi: 10.1038/nchem.2467. PMID: 26791893.